How should patients 80 years of age or older with colorectal carcinoma be treated? - Long-term and short-term outcome and postoperative cytokine levels
K. Sunouchi et al., How should patients 80 years of age or older with colorectal carcinoma be treated? - Long-term and short-term outcome and postoperative cytokine levels, DIS COL REC, 43(2), 2000, pp. 233-241
PURPOSE: The aim of this study was to determine how extensive resection aff
ects operative morbidity, mortality, and long-term survival in elderly pati
ents with colorectal cancer. METHODS: A total of 119 patients 80 years of a
ge or older were given a diagnosis of colorectal carcinoma at our hospital
between 1985 and 1997. Eleven patients who did not undergo surgery were exc
luded. The remaining 108 patients underwent laparotomy and were reviewed. S
erum levels of interleukin-G were measured perioperatively in 22 patients t
o assess the degree of operative stress. RESULTS: Potentially curative rese
ction was performed in 64 (88.9 percent) of the 72 patients in the active p
erformance status group and 13 (36.1 percent) of the 36 patients in the sed
entary performance status group (P < 0.001). The in-hospital mortality rate
was 8.3 percent in group the active performance status group and 38 percen
t in the sedentary performance status group (P = 0.007). Patients in the se
dentary performance status group and those who underwent emergency operatio
ns had higher levels of IL-G than patients in the active performance status
group or those who underwent elective operations. CONCLUSIONS: Preoperativ
e performance status, operative curability, and tumor stage have a signific
ant impact on outcome in patients with colorectal cancer who are 80 years o
f age or older. Knowledge of early postoperative response of IL-6 is useful
in predicting postoperative mortality and morbidity in this subgroup of pa
tients.